Event / Politics

US Mifepristone Access Legal Battle

← All events

Updated

Federal court proceedings over mifepristone mail access and FDA approval. Multiple states pursuing restrictive policies while others protect telehealth providers. Supreme Court and various courts addressing medication abortion availability.

4 reported locations
Geography of the reported facts
  1. Washington, District of Columbia, United States
  2. Louisiana, United States
  3. Hawaii, United States
  4. Lafayette, Louisiana, United States

The story so far

Daily activity

0 articles
0 articles

2026-08-19 to 2026-11-16 · UTC publication dates

Coverage begins 8 Apr, 02:07 UTC

Follow the documented timeline or explore the related reporting.

What happened

The facts
  1. Telehealth abortion access reaches one-fourth of all abortions by end of 2024

    Research found that by the end of 2024, one-fourth of all abortions in the United States were accessed through telehealth—representing a fivefold increase over two years. In 2025, women in states with abortion bans were more likely to obtain abortions by obtaining pills through telehealth than by traveling to other states.

    1 corroborating report

  2. Judge orders FDA to complete mifepristone review within six months

    Judge David Joseph directed the FDA to provide an update on its mifepristone investigation within six months. He stated that if the agency fails to complete its review and make necessary revisions to its rules within a reasonable timeframe, his analysis and the weight accorded to various factors would inevitably change, signaling he may reconsider his position.

    1 corroborating report

  3. Louisiana Attorney General vows to appeal mifepristone ruling to federal appeals court

    Louisiana Attorney General Liz Murrill announced she would appeal the federal court's decision to an appeals court, seeking to overturn FDA rules permitting mifepristone mail delivery. Murrill argued that the judge's opinion acknowledged Louisiana suffers irreparable harm daily while these rules remain in effect.

    1 corroborating report

  4. Hawaii judge rules FDA violated law by restricting mifepristone access

    A Hawaii federal judge ruled that the FDA violated the law by imposing restrictions on mifepristone, which is used for both abortion and miscarriage management.

    1 corroborating report

  5. Federal judge refuses to block mifepristone mail prescriptions nationwide

    U.S. District Judge David Joseph in Lafayette, Louisiana ruled against Louisiana Attorney General Liz Murrill's request to pause FDA rules allowing mifepristone to be dispensed by mail. The judge granted the government's request to put the case on hold temporarily, though he indicated the pause would not be indefinite and warned he could side with Louisiana later. The judge said plaintiffs are 'likely to succeed on the merits' but will await completion of an FDA study on the drug.

    1 corroborating report

  6. Trump administration approves additional generic mifepristone version

    The Trump administration approved an additional generic version of mifepristone, a decision that outraged anti-abortion advocacy groups. Mifepristone is used both for abortion and for miscarriage management.

    1 corroborating report

  7. Thirteen U.S. states maintain complete abortion bans at all pregnancy stages

    Louisiana is one of 13 states that currently enforce complete abortion bans prohibiting abortion at all stages of pregnancy. Similar court challenges to mifepristone mail rules are being pursued by Republican state officials in other districts.

    1 corroborating report

  8. Eight states enact laws protecting out-of-state abortion pill providers from prosecution

    Eight states have enacted laws designed to protect healthcare providers who prescribe abortion pills via telehealth and have them mailed into states with abortion bans. These laws aim to shield providers from legal liability in conservative states.

    1 corroborating report

  9. Louisiana criminalizes mifepristone provision across state lines with prosecutions

    Louisiana Attorney General Liz Murrill is pursuing criminal cases against two doctors—one in California and one in New York—accused of sending mifepristone pills to patients in Louisiana. California and New York have declined to extradite the doctors to face charges in Louisiana.

    1 corroborating report

  10. U.S. Supreme Court refuses to block mifepristone mail prescriptions in 2024

    In 2024, the U.S. Supreme Court refused to block filling prescriptions for mifepristone by mail. That case differed from the current Louisiana lawsuit because it was brought by anti-abortion doctors whom the Court determined lacked legal standing to challenge the FDA rules.

    1 corroborating report

Read the coverage